3 Results
Guidelines and Advice
Status: In-Review
ID: 7-21
ID: 7-21
May 2016
Drug
Jan 2022
Guidelines and Advice
Status: In-Review
ID: GL 2-33
ID: GL 2-33
Jun 2022